The Indian drugmaker Natco Pharma “said Wednesday it has informed Pfizer Inc. that it wants to make and sell a low-cost generic version of the U.S. company’s [drug] maraviroc for treating the HIV infection under a so-called ‘compulsory license’ [CL],” Dow Jones Newswires/Smart Money reports. “Natco Pharma’s move is significant because, if successful, the Indian generic drug maker will set a precedent for other Indian companies to override multinational drug makers’ patents for the treatments of diseases ranging from cancer to hypertension,” according to the new service.
Programs, Funding & Financing
India’s patent office “has rejected American drug maker Abbott Laboratories’ patent application for an HIV combination drug, allowing low-cost local drug makers to make and sell their generic versions in India and other countries where the medicine is not patented,” Economic Times reports (1/4). The drug under consideration was Abbott’s “Kaletra, which combines two antivirals, [lopinavir/ritonavir and] is one of the preferred second-line treatments to fight drug-resistant HIV, according to the World Health Organization, which recommends governments include it on their list of essential medicines,” Bloomberg/Businessweek writes (Narayan, 1/4).
Opinions: U.S. International Affairs Budget; Health Impacts Of Climate Change; Role Of U.N.; Drug Development, Free Trade
The U.S. ‘Must Continue To Have A Strong, AndÂ Effective International Affairs Budget’ Despite challenging economic times, “[t]wo areas we cannot afford to shortchange right now … are our national security and our economic prosperity, which is why we must continue to have a strong and effective International Affairs Budget,” U.S.…
Also In Global Health News: Schistosomiasis Control In Cambodia; Microbicide Gel Trial In Monkeys; Tobacco Use In China
IRIN Examines Schistosomiasis Control Efforts In Cambodia IRIN reports on how Cambodia’s efforts to control schistosomiasis, “a chronic and debilitating disease commonly known as snail fever,” have led to a drop in cases over the past decade. “Since 2002, the Cambodian government has overseen a vast deworming programme. In 2004,…
U.N. Secretary-General Ban Ki-moon announced the names of four experts to be part of an independent panel that will “investigate the source of Haiti’s cholera epidemic, which some Haitians blame on U.N. peacekeepers,” Reuters reports (Worsnip, 1/6).
Newborn Resuscitation Innovation Breeds Additional Innnovation: In a USAID “Impact” blog post, Lily Kak, USAID senior maternal and newborn health advisor, writes about the the Global Development Alliance, which represents a “new way of doing business in the field of newborn health and has now become a key USAID strategy…
On Friday, the Office of the U.N. Special Envoy to Haiti said that 63.6 percent of the aid international donors “pledged to Haiti in 2010 after a devastating earthquake nearly one year ago” has been disbursed, Deutsche Presse-Agentur/M&C reports (1/7).
CQ Today examines how Rep. Ileana Ros-Lehtinen (R-Fla.), House Foreign Affairs Committee chair, “has vowed to use her new [position] to take on the U.N. and some of its more controversial practices.” Ros-Lehtinen scheduled a public briefing titled ‘The United Nations: Urgent Problems that Need Congressional Action’ Jan. 12, during which the “committee will hear from a host of groups long critical of the U.N., including the Heritage Foundation and U.N. Watch,” according to the news service.
Also In Global Health News: NGOs, Business Schools; India’s Growing Presence In Africa; Water, Sanitation In Indonesia; Malaria Vaccine Trials
Financial Times Reports On Oxfam’s MBA Workshops Financial Times explores how the NGO Oxfam has started to “develop ethical trade workshops for MBA students in UK business schools, with a particular focus on overseas students” in the “hopes that by targeting the next generation of business leaders, it can influence…
Public health research data “must be made more widely available in the scientific community if researchers are to unlock its full potential and make progress in public health, the world’s top health funding agencies said Monday,” Reuters reports. “In a joint statement, 17 major health research funders from around the world pledged to work together to support ‘timely and responsible’ sharing of data gathered during studies on health,” the news service notes (Kelland, 1/10).